Grifols (GIKLY) Depreciation & Amortization (CF) (2010 - 2013)

Grifols (GIKLY) reported Depreciation & Amortization (CF) of $40970.5 for Q1 2013, down 1.03% on a YoY basis from $41398.2 in Q1 2012, and down 1.03% quarter-over-quarter from $41398.2 in Q1 2012.

Grifols (GIKLY) Depreciation & Amortization (CF) (2010 - 2013) Analysis & Trends

Grifols has reported Depreciation & Amortization (CF) for 4 years, with the latest figure at $40970.5 in Q1 2013.

  • For the quarter ending Q1 2013, Depreciation & Amortization (CF) fell 1.03% year-over-year to $40970.5; the trailing twelve-month figure through Dec 2013 stood at $40970.5 (down 1.03% YoY), and the FY2025 full-year result was $523.8 million, up 11.92% from the prior year.
  • Depreciation & Amortization (CF) for Q1 2013 stood at $40970.5, down from $41398.2 in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $122.2 million in Q4 2011, with the low at $40970.5 in Q1 2013.
  • Historically, Depreciation & Amortization (CF) has averaged $46.1 million across 4 years, with a median of $31.1 million in 2010.
  • Annual changes were most pronounced in 2011 — Depreciation & Amortization (CF) surged 96.51% — and 2013, when it slipped 1.03%.
  • Grifols' Depreciation & Amortization (CF) stood at $62.2 million in 2010, then surged by 96.51% to $122.2 million in 2011, then slumped by 99.97% to $41398.2 in 2012, then declined by 1.03% to $40970.5 in 2013.
  • The last three Depreciation & Amortization (CF) figures came in at $40970.5 (Q1 2013), $41398.2 (Q1 2012), and $122.2 million (Q4 2011), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 509.00 Mn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 2.00 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 188.00 Mn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 581.00 Mn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 1.12 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 93.00 Mn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 1.61 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 594.00 Mn
10 Grifols - - - -

Historic Data

Download Data
DateValue
Mar 31, 2013 40,970.52
Mar 31, 2013 40,970.52
Mar 31, 2012 41,398.23
Mar 31, 2012 41,398.23
Dec 31, 2011 122.15 Mn
Dec 31, 2011 122.15 Mn
Dec 31, 2010 62.16 Mn
Dec 31, 2010 62.16 Mn